{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:59:29Z","timestamp":1762955969049},"reference-count":61,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CHYR"],"published-print":{"date-parts":[[2019,1,29]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Hypertension, diabetes and neurodegenerative diseases are among the most prevalent medical problems around the world, costing millions of dollars to the medical health systems. Indeed, hypertension has been associated with higher risk for decline of cognition, as evidenced in patients with Alzheimer\u00b4s disease (AD). Furthermore, there is a clear relationship between hypertension and diabetes, reflecting substantial overlap in their etiology. Calcium (Ca2+) channel blockers (CCBs) have been classically prescribed for treating hypertension because of their mechanism of action due to reducing the influx of Ca2+ into the smooth muscles cells. In addition, many clinical and experimental studies have been demonstrating pleiotropic effects for CCBs. For instance, in hypertensive patients treated with CCBs, it can be observed lower incidence of neurodegenerative diseases such as AD. The virtual mechanism of action could be attributed to a restoration and maintenance of Ca2+ homeostasis, which is dysregulated in the neurodegenerative diseases, including also a reduction of neuronal apoptosis as part of these CCBs pleiotropic effects. Similarly, in hypertensive patients treated with CCBs, it can be observed an improvement of diabetes status such as glycemic control. A possible mechanism of action under debate could be attributed to a restoration of insulin secretion, then achieving glycemic control, and reduction of pancreatic \u03b2-cell apoptosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Considering the discovery of our group entitled \u201ccalcium paradox\u201d due to Ca2+\/cAMP signalling interaction, in this review I discussed the virtual involvement of this interaction in the pleiotropic effects of CCBs, including the possible role of the Ca2+\/cAMP signalling interaction in the association between hypertension and higher risk for the decline of cognition, and diabetes.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1573402114666180817113242","type":"journal-article","created":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T04:51:56Z","timestamp":1535345516000},"page":"32-39","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Hypertension, Diabetes and Neurodegenerative Diseases: Is there a Clinical Link through the Ca2+\/cAMP Signalling Interaction?"],"prefix":"10.2174","volume":"15","author":[{"given":"Leandro Bueno","family":"Bergantin","sequence":"first","affiliation":[{"name":"Department of Pharmacology-Universidade Federal de Sao Paulo-Escola Paulista de Medicina, Laboratory of Autonomic and Cardiovascular Pharmacology-55 11 5576-4973, Rua Pedro de Toledo, 669-Vila Clementino, Sao Paulo-SP, CEP: 04039-032, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.23736\/S0031-0808.18.03360-8","volume":"60","author":"Marfany A.","year":"2018","unstructured":"Marfany A, Sierra C, Camafort M, Dom\u00e9nech M, Coca A. High blood pressure, Alzheimer disease and antihypertensive treatment.","journal-title":"Panminerva Med"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejphar.2016.06.034","volume":"788","author":"Bergantin L.B.","year":"2016","unstructured":"Bergantin LB, Caricati-Neto A. Challenges for the pharmacological treatment of neurological and psychiatric disorders: Implications of the Ca\/cAMP intracellular signalling interaction.","journal-title":"Eur J Pharmacol"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ceca.2013.06.004","volume":"54","author":"Bergantin L.B.","year":"2013","unstructured":"Bergantin LB, Souza CF, Ferreira RM. Novel model for \u201ccalcium paradox\u201d in sympathetic transmission of smooth muscles: role of cyclic AMP pathway.","journal-title":"Cell Calcium"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"e00181","DOI":"10.1002\/prp2.181","volume":"3","author":"Caricati-Neto A.","year":"2015","unstructured":"Caricati-Neto A, Garcia AG, Bergantin LB. Pharmacological implications of the Ca\/cAMP signaling interaction: From risk for antihypertensive therapy to potential beneficial for neurological and psychiatric disorders.","journal-title":"Pharmacol Res Perspect"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tins.2008.06.005","volume":"31","author":"Mattson M.P.","year":"2008","unstructured":"Mattson MP, Bezprozvanny I. Neuronal calcium mishandling and the pathogenesis of Alzheimer\u2019s disease.","journal-title":"Trends Neurosci"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"e4593","DOI":"10.1097\/MD.0000000000004593","volume":"95","author":"Wu C.L.","year":"2016","unstructured":"Wu CL, Wen SH. A 10-year follow-up study of the association between calcium channel blocker use and the risk of dementia in elderly hypertensive patients.","journal-title":"Medicine (Baltimore)"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.diabres.2016.01.021","volume":"115","author":"Yulia K.","year":"2016","unstructured":"Yulia K, Anath S, Stuart JF, April PC, Monika MS. Calcium channel blocker use is associated with lower fasting serum glucose among adults with diabetes from the REGARDS study.","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11883-012-0227-2","volume":"14","author":"Bernard M.Y.C.","year":"2012","unstructured":"Bernard MYC, Chao L. Diabetes and hypertension: Is there a common metabolic pathway?","journal-title":"Curr Atheroscler Rep"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jdiacomp.2008.04.002","volume":"23","author":"Weycker D.","year":"2009","unstructured":"Weycker D, Nichols GA, O\u2019Keeffe-Rosetti M. Excess risk of diabetes in persons with hypertension.","journal-title":"Diabetes Complications"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2337\/db11-0955","volume":"61","author":"Xu G.","year":"2012","unstructured":"Xu G, Chen J, Jing G, Shalev A. Preventing beta-cell loss and diabetes with calcium channel blockers.","journal-title":"Diabetes"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/HYP.0000000000000053","volume":"68","author":"Iadecola C.","year":"2016","unstructured":"Iadecola C, Yaffe K, Biller J. Impact of hypertension on cognitive function. A scientific statement from the American Heart Association.","journal-title":"Hypertension"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1474-4422(05)70141-1","volume":"4","author":"Qiu C.","year":"2005","unstructured":"Qiu C, Winblad B, Fratiglioni L. The age dependent relation of blood pressure to cognitive function and dementia.","journal-title":"Lancet Neurol"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3233\/JAD-2012-120748","volume":"32","author":"Kennelly S.","year":"2012","unstructured":"Kennelly S, Collins O. Walking the cognitive \u201cminefield\u201d between high and low blood pressure.","journal-title":"J Alzheimers Dis"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3233\/JAD-150831","volume":"50","author":"Ashby E.L.","year":"2016","unstructured":"Ashby EL, Miners JS, Kehoe PG, Love S. Effects of hypertension and anti-hypertensive treatment on amyloid-\u00df plaque load and A\u00df- synthesizing and A\u00df-degrading enzymes in frontal cortex.","journal-title":"J Alzheimers Dis"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11906-017-0724-3","volume":"19","author":"Walker K.A.","year":"2017","unstructured":"Walker KA, Power MC, Gottesman RF. Defining the relationship between hypertension, cognitive decline, and dementia: A review.","journal-title":"Curr Hypertens Rep"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"827.e11","DOI":"10.1016\/j.neurobiolaging.2011.06.020","volume":"33","author":"Langbaum J.B.S.","year":"2012","unstructured":"Langbaum JBS, Chen K, Launer LJ. Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons.","journal-title":"Neurobiol Aging"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","volume":"42","author":"Gorelick P.B.","year":"2011","unstructured":"Gorelick PB, Scuteri A, Black SE. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association\/American Stroke Association.","journal-title":"Stroke"},{"key":"ref=18","volume":"3","author":"Caricati-Neto A.","year":"2017","unstructured":"Caricati-Neto A, Bergantin LB. Pharmacological modulation of neural Ca\/camp signaling interaction as therapeutic goal for treatment of Alzheimer\u2019s disease.","journal-title":"J Syst Integr Neurosci"},{"key":"ref=19","volume":"3","author":"Caricati-Neto A.","year":"2017","unstructured":"Caricati-Neto A, Bergantin LB. The passion of a scientific discovery: the \u201ccalcium paradox\u201d due to Ca\/camp interaction.","journal-title":"J Syst Integr Neurosci"},{"key":"ref=20","author":"Caricati-Neto A.","year":"","unstructured":"Caricati-Neto A, Bergantin LB. 2017 From a \u201ceureka insight\u201d to a novel potential therapeutic target to treat Parkinson\u2019s disease: The Ca\/camp signalling interaction.","journal-title":"J Syst Integr Neurosci4"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40263-015-0230-6","volume":"29","author":"Rouch L.","year":"2015","unstructured":"Rouch L, Cestac P, Hanon O. Antihypertensive drugs, prevention of cognitive decline and dementia: A systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms.","journal-title":"CNS Drugs"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","volume":"350","author":"Staessen J.A.","year":"1997","unstructured":"Staessen JA, Fagard R, Thijs L. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur).","journal-title":"Trial Investigators Lancet"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(98)03086-4","volume":"352","author":"Forette F.","year":"1998","unstructured":"Forette F, Seux ML, Staessen JA. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.","journal-title":"Lancet"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/aje\/153.1.72","volume":"153","author":"Di Bari M.","year":"2001","unstructured":"Di Bari M, Pahor M, Franse LV. Dementia and disability outcomes in large hypertension trials: Lessons learned from the systolic hypertension in the elderly program (SHEP) trial.","journal-title":"Am J Epidemiol"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/FJC.0b013e3181d26430","volume":"55","author":"Cheung B.M.","year":"2010","unstructured":"Cheung BM. The hypertension-diabetes continuum.","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1081\/CEH-200031945","volume":"26","author":"Landsberg L.","year":"2004","unstructured":"Landsberg L, Molitch M. Diabetes and hypertension: Pathogenesis, prevention and treatment.","journal-title":"Clin Exp Hypertens"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200003303421301","volume":"342","author":"Gress T.W.","year":"2000","unstructured":"Gress TW, Nieto FJ, Shahar E. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis risk in communities study.","journal-title":"N Engl J Med"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.2337\/dc08-0405","volume":"31","author":"Cheung B.M.","year":"2008","unstructured":"Cheung BM, Wat NM, Tso AW. Association between raised blood pressure and dysglycemia in Hong Kong Chinese.","journal-title":"Diabetes Care"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1242\/jeb.139.1.329","volume":"139","author":"Penner R.","year":"1988","unstructured":"Penner R, Neher E. The role of calcium in stimulus-secretion coupling in excitable and non-excitable cells.","journal-title":"J Exp Biol"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1124\/jpet.107.128819","volume":"324","author":"Miranda-Ferreira R.","year":"2008","unstructured":"Miranda-Ferreira R, de Pascual R, de Diego AM. Single-vesicle catecholamine release has greater quantal content and faster kinetics in chromaffin cells from hypertensive, as compared with normotensive, rats.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1124\/jpet.108.147413","volume":"329","author":"Miranda-Ferreira R.","year":"2009","unstructured":"Miranda-Ferreira R, de Pascual R, Caricati-Neto A, Gandia L, Jurkiewicz A, Garcia AG. Role of the endoplasmic reticulum and mitochondria on quantal catecholamine release from chromaffin cells of control and hypertensive rats.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejphar.2010.03.044","volume":"636","author":"Miranda-Ferreira R.","year":"2010","unstructured":"Miranda-Ferreira R, de Pascual R, Smaili SS. Greater cytosolic and mitochondrial calcium transients in adrenal medullary slices of hypertensive, compared with normotensive rats.","journal-title":"Eur J Pharmacol"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0002-9343(88)90397-X","volume":"85","author":"Draznin B.","year":"1988","unstructured":"Draznin B. Intracellular calcium, insulin secretion, and action.","journal-title":"Am J Med"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4142\/jvs.2017.18.3.261","volume":"18","author":"Ahn C.","year":"2017","unstructured":"Ahn C, Kang J-HChanghwan Ahn, Ji-Houn Kang, Eui-Bae, Jeung E-B. Calcium homeostasis in diabetes mellitus.","journal-title":"J Vet Sci"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/361031a0","volume":"361","author":"Bliss T.V.","year":"1993","unstructured":"Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus.","journal-title":"Nature"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/0959-4388(95)80045-X","volume":"5","author":"Larkman A.U.","year":"1995","unstructured":"Larkman AU, Jack JJ. Synaptic plasticity: Hippocampal LTP.","journal-title":"Curr Opin Neurobiol"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/377115a0","volume":"377","author":"Nicoll R.A.","year":"1995","unstructured":"Nicoll RA, Malenka RC. Contrasting properties of two forms of long-term potentiation in the hippocampus.","journal-title":"Nature"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.2337\/diabetes.51.2007.S83","volume":"51","author":"Bratanova-Tochkova T.K.","year":"2002","unstructured":"Bratanova-Tochkova TK, Cheng H, Daniel S. Triggering and augmentation mechanisms, granule pools, and biphasic insulin secretion.","journal-title":"Diabetes"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1152\/physrev.1980.60.2.442","volume":"60","author":"Hedeskov C.J.","year":"1980","unstructured":"Hedeskov CJ. Mechanism of glucose-induced insulin secretion.","journal-title":"Physiol Rev"},{"key":"ref=40","first-page":"37","volume":"93","author":"Henquin J.C.","year":"1985","unstructured":"Henquin JC. The interplay between cyclic AMP and ions in the stimulus-secretion coupling in pancreatic B-cells.","journal-title":"Arch Int Physiol Biochim"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF01223617","volume":"16","author":"Sharp G.W.","year":"1979","unstructured":"Sharp GW. The adenylate cyclase-cyclic AMP system in islets of Langerhans and its role in the control of insulin release.","journal-title":"Diabetologia"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2337\/diab.18.12.797","volume":"18","author":"Sutherland E.W.","year":"1969","unstructured":"Sutherland EW, Robison GA. The role of cyclic AMP in the control of carbohydrate metabolism.","journal-title":"Diabetes"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0898-6568(97)00178-2","volume":"10","author":"Fujita-Yoshigaki J.","year":"1998","unstructured":"Fujita-Yoshigaki J. Divergence and convergence in regulated exocytosis: the characteristics of cAMP-dependent enzyme secretion of parotid salivary acinar cells.","journal-title":"Cell Signal"},{"key":"ref=44","author":"Bergantin LB","year":"","unstructured":"Bergantin LB, Caricati-Neto A. Insight from \u201cCalcium Paradox\u201d due to Ca2+\/cAMP interaction: Novel pharmacological strategies for the treatment of depression. Int Arch Clin Pharmacol 2016; 2: 007."},{"key":"ref=45","author":"Bergantin LB","year":"","unstructured":"Bergantin LB, Caricati-Neto A. Novel concepts for clinical pharmacology from \"Calcium Paradox\" due to neuronal interaction between signalling pathways mediated by Ca2+ and cAMP: From 1975 to 2017. Int Arch Clin Pharmacol 2017; 3: 013."},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.4172\/2168-975X.1000e125","volume":"6","author":"Bergantin L.B.","year":"2017","unstructured":"Bergantin LB. Neurodegenerative diseases: Where to go from now? thought provoking through Ca\/cAMP signaling interaction.","journal-title":"Brain Disord Ther"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.4172\/2329-6895.1000e124","volume":"5","author":"Bergantin L.B.","year":"2017","unstructured":"Bergantin LB. Neurological Disorders: Is There a Horizon? Emerging Ideas from the Interaction between Ca and Camp Signaling Pathways.","journal-title":"J Neurol Disord"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"33704","DOI":"10.1074\/jbc.M004278200","volume":"275","author":"Giovannucci D.R.","year":"2000","unstructured":"Giovannucci DR, Groblewski GE, Sneyd J, Yule DI. Targeted phosphorylation of inositol 1,4,5-trisphosphate receptors selectively inhibits localized Ca release and shapes oscillatory Ca signals.","journal-title":"J Biol Chem"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1074\/jbc.M106609200","volume":"277","author":"Bruce J.I.","year":"2002","unstructured":"Bruce JI, Shuttleworth TJ, Giovannucci DR, Yule DI. Phosphorylation of inositol 1,4,5-trisphosphate receptors in parotid acinar cells. A mechanism for the synergistic effects of cAMP on Ca signaling.","journal-title":"J Biol Chem"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1042\/bj3301411","volume":"330","author":"Chatton J.Y.","year":"1998","unstructured":"Chatton JY, Cao Y, Liu H, Stucki JW. Permissive role of cAMP in the oscillatory Ca response to inositol 1,4,5-trisphosphate in rat hepatocytes.","journal-title":"Biochem J"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1172\/JCI42992","volume":"120","author":"Lee R.J.","year":"2010","unstructured":"Lee RJ, Foskett JK. cAMP-activated Ca signaling is required for CFTR-mediated serous cell fluid secretion in porcine and human airways.","journal-title":"J Clin Invest"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1113\/jphysiol.1961.sp006791","volume":"159","author":"Douglas W.W.","year":"1961","unstructured":"Douglas WW, Rubin RP. The role of calcium in the secretory response of the adrenal medulla to acetylcholine.","journal-title":"J Physiol"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/276620a0","volume":"276","author":"Baker P.F.","year":"1978","unstructured":"Baker PF, Knight DE. Calcium-dependent exocytosis in bovine adrenal medullary cells with leaky plasma membranes.","journal-title":"Nature"},{"key":"ref=54","first-page":"R43","volume":"287","author":"Kreye V.A.","year":"1975","unstructured":"Kreye VA, Luth JB. Proceedings: Verapamil-induced phasic contractions of the isolated rat vas deferens.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1476-5381.1981.tb10424.x","volume":"73","author":"French A.M.","year":"1981","unstructured":"French AM, Scott NC. A comparison of the effects of nifedipine and verapamil on rat vas deferens.","journal-title":"Br J Pharmacol"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0014-2999(87)90636-4","volume":"140","author":"Moritoki H.","year":"1987","unstructured":"Moritoki H, Iwamoto T, Kanaya J, Maeshiba Y, Ishida Y, Fukuda H. Verapamil enhances the non-adrenergic twitch response of rat vas deferens.","journal-title":"Eur J Pharmacol"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"29","DOI":"10.17756\/jnen.2017-024","volume":"3","author":"Bergantin L.B.","year":"2017","unstructured":"Bergantin LB, Caricati-Neto A. Emerging concepts for neuroscience field from Ca\/cAMP signalling interaction.","journal-title":"J Neurol Exp Neurosci"},{"key":"ref=58","volume":"3","author":"Bergantin L.B.","year":"2017","unstructured":"Bergantin LB. Advances for the pharmacotherapy of depression - Presenting the rising star: Ca\/camp signaling interaction.","journal-title":"J Syst Integr Neurosci"},{"key":"ref=59","author":"Bergsten P.","year":"2003","unstructured":"Bergsten P.","journal-title":"Calcium dysregulation, insulin release and the pathogenesis of diabetesAdv Cell Aging Gerontol"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nm0395-244","volume":"1","author":"Sommer N.","year":"1995","unstructured":"Sommer N, Loschmann PA, Northoff GH. The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis.","journal-title":"Nat Med"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1124\/jpet.111.179358","volume":"338","author":"Xiao L.","year":"2011","unstructured":"Xiao L, O\u2019Callaghan JP, O\u2019Donnell JM. Effects of repeated treatment with phosphodiesterase-4 inhibitors on cAMP signaling, hippocampal cell proliferation, and behavior in the forced-swim test.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Current Hypertension Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/164730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T09:47:47Z","timestamp":1661852867000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/164730\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,29]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1,29]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573402114666180817113242","relation":{},"ISSN":["1573-4021"],"issn-type":[{"value":"1573-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1,29]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-05-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}